MedPath

Outcomes of endoscopic transpapillary gallbladder stenting (ETGS) in gallstones with acute cholangitis patients whose cholecystectomy are deferred: a randomized controlled trial

Phase 3
Conditions
gallstone-associated acute cholangitis
Gallstone, Cholangitis, Transpapillary gallbladder stenting
Registration Number
TCTR20240624004
Lead Sponsor
The Gastroenterological Association of Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
176
Inclusion Criteria

Age >/= 18 years old
- Gallstone with acute cholangitis patients
- Evaluated by surgical team and cholecystectomy is deferred

Exclusion Criteria

- Acute cholecystitis
- Acute biliary pancreatitis
- Hemodynamic unstable
- Uncontrolled coagulopathy
- Schedule for cholecystectomy within 3 months
- Previous ERCP
- Refuse to provide informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pancreatobiliary events 3 months diagnosis by physician
Secondary Outcome Measures
NameTimeMethod
technical success rate at the end of the intervention by fluoroscopy,clinical success rate 72 hours Proportion of patients who have resolution of symptoms, liver function test and leukocytosis,procedural related adverse events 2 weeks Proportion of patients who develop adverse events after procedure,rate of pancreatobiliary events during 6-month follow up 6 months Proportion of patients who develop pancreatobiliary events during 6-month follow up
© Copyright 2025. All Rights Reserved by MedPath